Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


KCI Lobbies Congress Over Next Round Of Medicare Competitive Bidding

This article was originally published in The Gray Sheet

Executive Summary

Executives at device maker KCI want Washington policy-makers to consider the potential safety and cost impacts of including negative pressure wound therapy products in the next round of Medicare's competitive bidding program.

You may also be interested in...

Changing Form, But Not Function: Smith & Nephew Expands NPWT Market

The drive toward cost-effectiveness and expanded patient access have spurred device developers to take proven therapies or procedures and re-engineer them in ways that make them simpler, less expensive and easier to use. Now, the biggest player in wound care is following suit. In January, Smith & Nephew PLC announced that the FDA had cleared PICO, its new, single-use, pocket-sized negative pressure wound therapy (NPWT) system.

CMS In Brief

News from the Medicare agency includes updates on the DME competitive bidding program, overpayment recoveries and obesity screening.

ConvaTec Makes Competing Bid For Wound Care Company Kinetic Concepts

Kinetic Concepts Inc. would have to pay a break-up fee of $51.8 million to its current private equity merger partners if it accepts a superior, rival proposal from ostomy and wound care device maker ConvaTec.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts